CA
Carisma Therapeutics, Inc.
CARM · OTC
$0.00 -12.50% (-$0.00)
1M -69.57%
Market Cap $33.5K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/E 0.00x
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 9.57%
Book val. growth N/A
EPS growth N/A
Profitability
63 /100
Moderate Op. margin 20.61%
Gross margin 98.05%
FCF margin 42.59%
Quality
43 /100
Average Asset turnover 8.03x
ROIC 10,330.50%
ROA 122.70%
Debt
79 /100
Low Net debt/EBITDA -0.15x
Current ratio 0.86x
Debt/Assets N/A
Stability
13 /100
Unstable EPS volatility 2,319.95%
Beta -9.03x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CARM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
46
Headquarters
Philadelphia
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report